App-Quantinova.ai

The Modified Mayo Endoscopic Score (Mmes): a New Score for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis (UC) Patients

Talat Bessissow - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

N/A

Biomarker Panel for Prediction of Mucosal Healing in Patients With Crohn's Disease Under Infliximab Therapy

Talat Bessissow - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Crohn's disease

Infliximab

?E Integrin Expression As a Predictive Biomarker for Induction of Clinical Remission by Etrolizumab: Analysis of a Phase II Trial in Moderate-to-Severely Active Ulcerative Colitis

Gaik Wei Tew - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Etrolizumab

Increased Expression of T Cell Associated Genes in Baseline Biopsies From TNF Antagonist NaiVE Patients That Achieve Remission With Etrolizumab Treatment in a Phase II Trial in Moderate to Severely Active Ulcerative Colitis

Jason Hackney - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Etrolizumab

Dietary Fat Intake, Fecal Calprotectin and Metabolomic Profiles Predict Relapse of Ulcerative Colitis

Floris F. van den Brand - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

N/A

A Population-Based Comparison of Influenza Vaccination Use Among Individuals With and Without IBD

Zoann Nugent - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Influenza

N/A

Predictors of Readmissions and Outcomes Among Patients Hospitalized for Inflammatory Bowel Disease

Natasha Bollegala - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Inflammatory bowel disease

N/A

Women With Inflammatory Bowel Disease Are At Higher Risk of Gestational Diabetes: a Novel Finding

Gilaad Kaplan - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Inflammatory bowel disease

N/A

A Validated Web-Based Patient Communication Tool to Display Individualized Crohn's Disease Predicted Outcomes Based on Clinical, Serologic and Genetic Variables

Henry Horton - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Anal fistula

N/A

The Non Use of IBD-Specific Prescription Medications in Patients With IBD

Laura Targownik - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Crohn's disease

Glucocorticoid

Factors Associated With Large Increases in Self-Reported Health Status in Infliximab-Treated IBD Patients

Kuhan Perampaladas - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Infliximab

Crohn's Disease Outpatients Treated With Adalimumab Have an Earlier Loss of Response and Requirement for Dose Intensification Compared to Infliximab

Vivian Huang - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Anal fistula

Oraprine

Outpatients With Ulcerative Colitis Being Treated With Adalimumab and Infliximab Have Similar Rates of Loss of Response

Christopher Ma - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Oraprine

Subcutaneous Ustekinumab for the Treatment of Anti-TNF Resistant Crohn's Disease - the McGill Experience

Waqqas Afif - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriasis

IL-12

Impact of Patient Weight on Adalimumab Efficacy in Crohn's Disease - a Pilot Study

Uri Kopylov - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory bowel disease

Adalimumab

Is There a Higher Rate of Infliximab Dose Optimization in Initial Responders Between UC and CD Cases?

Joanne M. Stempak - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Infliximab

Site-Specific Immunomodulation - a Novel Therapeutic Approach for the Management of Crohn's Disease

Simon Sutcliffe - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Crohn's disease

N/A

Thiopurines in the Management of Crohn's Disease: Safety and Efficacy Profile in Patients With Intermediate and Normal Thiopurine Methyltransferase Activity, a Retrospective Study

Xuanqian Xie - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Crohn's disease

Oraprine

Infliximab Therapy in Pediatric Crohn's Disease: Results From Develop, a Multicenter Prospective Inflammatory Bowel Disease Registry

Salvatore Cucchiara - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Inflammatory bowel disease

Infliximab

Increased Prevalence of Gluten Related Disorders in Patients With Barret-s Esophagus: the Impact on the Development of Dysplasia

Reena Khanna - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastroesophageal reflux disease

N/A

Filters

28841 Abstracts